Clinical TrialPTSDCompleted

Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD

This observational cohort study (n=30) explored perceptions of MDMA-Assisted Therapy among veterans with PTSD.

Target Enrollment
30 participants
Study Type
Phase NA observational
Design
Non-randomized

Detailed Description

This mixed-method, cross-sectional observational cohort (n=30) collected qualitative interviews and brief symptom questionnaires from veterans enrolled in VA care to explore perceptions of MDMA-assisted therapy for PTSD.

Interviews used a story-completion task in which participants completed a vignette about a fictitious veteran offered MDMA-assisted therapy; transcripts will be thematically analysed and coded to quantify theme prevalence and examine associations with symptom severity and demographics to inform VA educational and rollout efforts.

Study Protocol

Preparation

sessions

Dosing

sessions

Integration

sessions

Therapeutic Protocol

Manualized psychotherapy included

Participants

Ages
18 – 99
Sexes
Male & Female

Inclusion Criteria

  • Inclusion Criteria:
  • Veterans enrolled in VA care
  • Active diagnosis of PTSD, as determined by the referring provider or confirmed by medical records.
  • Age 18 or older
  • Fluent in written and spoken English

Exclusion Criteria

  • Exclusion Criteria:
  • Cognitively impaired to the extent that patient cannot comprehend the survey
  • Has already completed the interview

Study Details

  • Status
    Completed
  • Phase
    Phase NA
  • Type
    observational
  • Design
    Non-randomized
  • Target Enrollment30 participants
  • Timeline
    Start: 2022-08-08
    End: 2023-03-23
  • Topic
    PTSD

Locations

Stratton VA Medical Center — Albany, New York, United States

Your Library